DRUG DESIGNATION: Pfizer says U.S. regulators have classified its experimental pill for advanced, often-deadly breast cancer as a breakthrough therapy. That's done to speed up development and review of treatments seen as big advances.
THE RESEARCH: Palbociclib is in late-stage testing as an initial treatment for the biggest subgroup of postmenopausal women with advanced breast cancer — those in whom tumor growth is fueled by the hormone estrogen but not by a growth-promoting protein called HER2.
MORE TESTING: Pfizer, which has made research on cancer medicines a priority, also is testing palbociclib as a treatment for other cancers.
'Entitlement reform, Hillary-style'! Clinton lets Ed Henry know what he's entitled to [Vine]
Obama’s NLRB just redefined the word “employer” and it’s going to be bad - Hot Air
Republican Party, R.I.P. (1854 - 2016) | RedState
Nick Adams - Not a Single Illegal Immigrant in 7 Months... In Australia
Mike Adams - Get Out of My Class and Leave America
World's Most Powerful Crossbow! Scorpyd Ventilator Extreme - Bearing Arms - crossbow, Scorpyd
Small But Honest Columnist Again Forced to Correct Highest-Rated Show on Cable TV | Human Events